Metraipolis › archive › dc_d8ec0a8656cb

Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study — Europe PMC PMID:41089835

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41089835
DOI
10.3389/fphar.2025.1642137
License (as archived)
solo-consultazione
Archived
2026-11-09T17:20:45.315Z
SHA-256 of the archived text
6bfdee35ebec4d063dcd5eb513622307ff9e92e7848ae5effd4ddec127487379
Stable URL of this page
https://metraipolis.com/documento/dc_d8ec0a8656cb

How to cite

Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study — Europe PMC PMID:41089835 — Europe PMC (en), https://europepmc.org/article/MED/41089835 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d8ec0a8656cb (Metraipolis archive dc_d8ec0a8656cb, sha256 6bfdee35ebec4d063dcd5eb513622307ff9e92e7848ae5effd4ddec127487379)
BibTeX
@misc{dcd8ec0a8656cb,
  title = {Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study — Europe PMC PMID:41089835},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41089835},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d8ec0a8656cb; sha256 6bfdee35ebec4d063dcd5eb513622307ff9e92e7848ae5effd4ddec127487379},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41089835. Agents can read the archived copy with the MCP tool read_document.